Table 5 Pharmacological groups not recommended in the elderly that generated PREFASEG alerts from January 2016–December 2018
Not recommended pharmacological groups | Alerts generated | Total accepted | % Accepted |
|---|---|---|---|
Benzodiazepines, hypnotics, and sedatives | 172,574 | 47,966 | 27 |
Anti-inflammatory and anti-rheumatic (NSAIDs, COXIBS) | 94,034 | 20,627 | 22 |
Antihypertensives | 34,542 | 10,310 | 30 |
Digestive system (otilonium, metoclopramide, glibenclamide, chlorporpamide) | 31,496 | 8945 | 28 |
Chronic obstructive pulmonary disease treatments (theophylline) | 19,285 | 4758 | 25 |
Central action muscle relaxants (cyclobenzaprine) | 18,170 | 7521 | 41 |
Tricyclic antidepressants and Fluoxetine | 17,289 | 5654 | 33 |
Peripheral vasodilators (pentoxifilline, nicergoline, nafthydrofuril) | 16,958 | 6621 | 39 |
Respiratory system (systemic antihistamines) | 14,219 | 4917 | 35 |
Hormone therapy (megestrol) | 10,776 | 2631 | 24 |
Urinary antispasmodics (oxybutynin) | 7018 | 2495 | 36 |
Antithrombotics (cilostazol) | 3270 | 1100 | 34 |
Beta-blockers (sotalol) | 1105 | 392 | 35 |
Opioid and anti-migraine pain relievers | 868 | 342 | 39 |
Antiparkinsonian drugs | 316 | 105 | 33 |